These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2185492)

  • 41. Growth of human T lymphocytes: an analysis of interleukin 2 and its cellular receptor.
    Greene WC; Leonard WJ; Depper JM
    Prog Hematol; 1986; 14():283-301. PubMed ID: 2418464
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclosporin A and the immune response to transplantation antigens.
    Hess AD
    Lymphokine Res; 1982; 1(2):23-7. PubMed ID: 6239956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanism of action of cyclosporin A].
    Wagner H; Hardt C; Heeg K
    Internist (Berl); 1985 Sep; 26(9):530-3. PubMed ID: 2933358
    [No Abstract]   [Full Text] [Related]  

  • 44. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
    MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
    [No Abstract]   [Full Text] [Related]  

  • 46. Cyclosporin. Mechanism of action: in vitro studies.
    Hess AD; Colombani PM
    Prog Allergy; 1986; 38():198-221. PubMed ID: 2941763
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to cyclosporine A.
    Merćep M; Noguchi PD; Ashwell JD
    J Immunol; 1989 Jun; 142(11):4085-92. PubMed ID: 2785572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The immune response and alterations induced by immunosuppressive drugs.
    Edgington TS
    Ann Ist Super Sanita; 1987; 23(4):719-25. PubMed ID: 3330642
    [No Abstract]   [Full Text] [Related]  

  • 51. In vivo expression and regulation of murine IL 2 receptors after antigen sensitization.
    Butler LD; DeRiso PE; Marder P; Scheetz ME
    J Immunol; 1987 Jan; 138(2):470-7. PubMed ID: 3098844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cell activation via Leu-23 (CD69).
    Testi R; Phillips JH; Lanier LL
    J Immunol; 1989 Aug; 143(4):1123-8. PubMed ID: 2501389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective inhibition of immunoregulatory cell functions by cyclosporin A.
    Tosato G; Pike SE; Koski IR; Blaese RM
    J Immunol; 1982 May; 128(5):1986-91. PubMed ID: 6278023
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclosporine A does not prevent expression of biologically active IL 2 receptors in vitro.
    Bloemena E; van Oers MH; Weinreich S; Yong SL; Schellekens PT
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):131-5. PubMed ID: 3129838
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclosporine A inhibits lymphocyte activation at more than one site in vivo.
    Lai KN; Leung JC; Lai FM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):878-80. PubMed ID: 2650287
    [No Abstract]   [Full Text] [Related]  

  • 56. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action.
    Colombani PM; Hess AD
    Biochem Pharmacol; 1987 Nov; 36(22):3789-93. PubMed ID: 3318839
    [No Abstract]   [Full Text] [Related]  

  • 58. Cyclosporin as a probe for different modes of lymphocyte activation.
    Klaus GG
    Ann Inst Pasteur Immunol; 1987; 138(4):626-8. PubMed ID: 3499915
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclosporine-sensitive and cyclosporine-insensitive modes of B cell stimulation.
    Klaus GG
    Transplantation; 1988 Aug; 46(2 Suppl):11S-14S. PubMed ID: 2841782
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of cyclosporine on total lymphocyte and T-cell counts in renal-transplant recipients.
    Shen S; Weir M; Dagher F; Bentley F; Revie D; Ordonez J; Chretien P
    N Engl J Med; 1986 Feb; 314(7):447-8. PubMed ID: 3511380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.